Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11773070 Dihydrooxadiazinones

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Adrian Tersteegen

Manuel Ellermann

Alex Burgin

Charlotte Christine Kopitz

Martin Lange

Philip Lienau

Matthew Meyerson

Xiaoyun Wu

...

Date of Patent

October 3, 2023

Patent Application Number

17865236

Date Filed

July 14, 2022

Patent Citations

US Patent 10287353 Combination therapies of HDAC inhibitors and PD-1 inhibitors

US Patent 10385131 Combination therapies of HDAC inhibitors and PD-L1 inhibitors

US Patent 10729680 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines

US Patent 11427553 Dihydrooxadiazinones

US Patent 8501731 Derivatives of 6[3-(trifluoromethyl)phenyl]pyridazin-3(2H)-one having antitumor activity

US Patent 9212146 Substituted pyridazinones for the treatment of tumors

US Patent 9549932 2-(morpholin-4-yl)-1,7-naphthyridines

Patent Primary Examiner

Taofiq A. Solola

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11773070 Dihydrooxadiazinones

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.